You just read:

Eisai Announces Latest Data for LENVIMA® (lenvatinib) in Combination with Everolimus for Advanced Non-Clear Cell Renal Cell Carcinoma

News provided by

Eisai Inc.

Feb 15, 2020, 10:00 ET